Monind (532078)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹22 |
| Market Cap | ₹8.1 Cr |
| P/E Ratio | 0 |
| ROCE | 0% |
| ROE | 5.28% |
| Dividend Yield | 0% |
| Profit Growth | -9.68% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹24.34 — ₹31.04 |
| Sector | Industrial Products |
Strengths
- Trailing ROE is positive at 5.28%, suggesting some equity base existed before the latest loss.
- Absolute market cap of ₹8 Cr means the rupee downside is limited if an investor chooses only a very small speculative position.
- No dividend payout means there is no cash drain to shareholders, though there is also no earnings visibility.
- Iron and steel products can involve tangible assets, but the data given does not confirm any value.
Concerns
- Latest quarter sales are ₹0 Cr with a net loss of ₹1 Cr, meaning the business is currently generating no revenue.
- Piotroski F-Score of 2/9 indicates very poor financial health and likely deterioration.
- ROCE is 0%, profit growth is -9.68%, and there is no dividend yield.
- Missing book value, debt/equity, and promoter holding data prevents any margin-of-safety analysis, and the price is below the 52-week low.
AI Analysis
When I look at Monind, the first thing I see is not a business but the absence of one. The latest quarter shows sales of ₹0 crore and a net loss of ₹1 crore. A company cannot be valued on zero revenue and negative profit. The ₹22 price gives a market cap of just ₹8 crore, which is tiny, but smallness is not a margin of safety. Graham taught me to anchor valuation to assets and earning power; here book value, debt/equity, and promoter holding are all unavailable, so I have no balance-sheet anchor. ROCE is 0%, profit growth is down 9.68%, and the Piotroski F-score is a dismal 2/9. That is a loud warning of financial deterioration, not a clue of hidden value. The stock trades at ₹22, below its 52-week range low of ₹24.34. In my experience, when a stock keeps making new lows with no revenue, it is usually a falling knife, not a bargain. There is no dividend, no sales growth, and not enough data for a FairStock score. I cannot estimate intrinsic value, so the rational move is to pass. Buffett's first rule is don't lose money; buying this could mean losing money without any visible catalyst. If this were a genuine turnaround, I would need to see a credible plan, new orders, positive cash flow, and management with skin in the game. None are visible from these figures. I would put this in the 'too difficult' pile. Perhaps a deep-value specialist could find something in an audited balance sheet, but the data given does not support a Graham-style margin of safety. I need facts, not hope.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer